Mesenchymal stem cells in bone and cartilage regeneration

Regenerative Medicine and Cell Therapy

Volumn , Issue , 2013, Pages 131-153

  Baghaban Eslaminejad, Mohamadreza ^a   Zomorodian, Elham ^a   Bagheri, Fatemeh ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969293871     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-098-4_7     Document Type: Chapter

References (129)

1. Rodan GA (1992) Introduction to bone biology. Bone 13(Suppl 1):S3-S6.
2. Green D, Walsh D, Mann S, Oreffo RO (2002) The potential of biomimesis in bone tissue engineering: lessons from the design and synthesis of invertebrate skeletons. Bone 30(6):810-815.
3. Posner AS (1985) The mineral of bone. Clin Orthop Relat Res 200:87-99.
4. Rey C, Kim HM, Gerstenfeld L, Glimcher MJ (1995) Structural and chemical characteristics and maturation of the calcium-phosphate crystals formed during the calcification of the organic matrix synthesized by chicken osteoblasts in cell culture. J Bone Miner Res 10(10):1577-1588.
5. Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG (1992) Structure, expression, and regulation of themajor noncollagenous matrix proteins of bone. ClinOrthop RelatRes 281:275-294.
6. Robey PG (1996) Vertebrate mineralized matrix proteins: structure and function. Connect Tissue Res 35(1-4):131-136.
7. Maurer P, Hohenester E, Engel J (1996) Extracellular calcium-binding proteins. Curr Opin Cell Biol 8(5):609-617.
8. Sasaki T, Hohenester E, Gohring W, Timpl R (1998) Crystal structure and mapping by sitedirected mutagenesis of the collagen-binding epitope of an activated form of BM-40/ SPARC/osteonectin. EMBO J 17(6):1625-1634
9. de Oliveira PT, Nanci A (2004) Nanotexturing of titanium-based surfaces upregulates expression of bone sialoprotein and osteopontin by cultured osteogenic cells. Biomaterials 25(3):403-413.
10. Terai K, Takano-Yamamoto T, Ohba Y, Hiura K, Sugimoto M, Sato M, Kawahata H, Inaguma N, Kitamura Y, Nomura S (1999) Role of osteopontin in bone remodeling caused by mechanical stress. J Bone Miner Res 14(6):839-849.
11. Ducy P, Geoffroy V, Karsenty G (1996) Study of osteoblast-specific expression of one mouse osteocalcin gene: characterization of the factor binding to OSE2. Connect Tissue Res 35(1-4):7-14.
12. Moore KL (1992) Clinically oriented anatomy, 3rd edn. Williams & Wilkins, Baltimore.
13. Junqueira LCU, Carneiro J, Contopoulos AN (1975) Basic histology. In: A concise medical library for practitioner and student. p. v. Lange Medical Publications, Los Altos.
14. Gartner LP, Hiatt JL (2007) Color textbook of histology, 3rd edn. Saunders/Elsevier, Philadelphia.
15. Braddock M, Houston P, Campbell C, Ashcroft P (2001) Born again bone: tissue engineering for bone repair. News Physiol Sci 16:208-213.
16. Burchardt H, Enneking WF (1978) Transplantation of bone. Surg Clin North Am 58(2):403-427.
17. Gazdag AR, Lane JM, Glaser D, Forster RA (1995) Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 3(1):1-8.
18. Suh H (2000) Tissue restoration, tissue engineering and regenerative medicine. Yonsei Med J 41(6):681-684.
19. Ikada Y (2006) Challenges in tissue engineering. J R Soc Interface 3(10):589-601.
20. Damien CJ, Parsons JR (1991) Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 2(3):187-208.
21. Finkemeier CG (2002) Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 84- A(3):454-464.
22. Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA, Muller TE, Rupp RG, Maki T, Monaco AP et al (1991) Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci U S A 88(24):11100-11104.
23. Butler D (1998) Poll reveals backing for xenotransplants. Nature 391(6665):315.
24. Zhang P, Hamamura K, Yokota H (2008) A brief review of bone adaptation to unloading. Genomics Proteomics Bioinformatics 6(1):4-7.
25. Jacobs JJ, Sumner DR, Galante JO (1993) Mechanisms of bone loss associated with total hip replacement. Orthop Clin North Am 24(4):583-590.
26. Buckwalter JA (1983) Articular cartilage. Instr Course Lect 32:349-370.
27. Poole CA (1997) Articular cartilage chondrons: form, function and failure. J Anat 191(Pt 1): 1-13.
28. Bhosale AM, Richardson JB (2008) Articular cartilage: structure, injuries and review of management. Br Med Bull 87:77-95.
29. Eyre D (2002) Collagen of articular cartilage. Arthritis Res 4(1):30-35.
30. Buckwalter JA, Mankin HJ (1998) Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 47:477-486.
31. Darling EM, Hu JC, Athanasiou KA (2004) Zonal and topographical differences in articular cartilage gene expression. J Orthop Res 22(6):1182-1187.
32. Becerra J, Andrades JA, Guerado E, Zamora-Navas P, Lopez-Puertas JM, Reddi AH (2010) Articular cartilage: structure and regeneration. Tissue Eng Part B Rev 16(6):617-627.
33. Dhinsa BS, Adesida AB (2012) Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Curr Stem Cell Res Ther 7(2):143-148.
34. Frenkel SR, Di Cesare PE (1999) Degradation and repair of articular cartilage. Front Biosci 4:D671-D685.
35. Mithoefer K, McAdams TR, Scopp JM, Mandelbaum BR (2009) Emerging options for treatment of articular cartilage injury in the athlete. Clin Sports Med 28(1):25-40.
36. Buckwalter JA, Lohmander S (1994) Operative treatment of osteoarthrosis. Current practice and future development. J Bone Joint Surg Am 76(9):1405-1418.
37. Hangody L, Kish G, Karpati Z, Udvarhelyi I, Szigeti I, Bely M (1998) Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics 21(7):751-756.
38. Rose T, Craatz S, Hepp P, Raczynski C, Weiss J, Josten C, Lill H (2005) The autologous osteochondral transplantation of the knee: clinical results, radiographic findings and histological aspects. Arch Orthop Trauma Surg 125(9):628-637.
39. Williams RJ 3rd, Ranawat AS, Potter HG, Carter T, Warren RF (2007) Fresh stored allografts for the treatment of osteochondral defects of the knee. J Bone Joint Surg Am 89(4):718-726.
40. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331(14):889-895.
41. Schnabel M, Marlovits S, Eckhoff G, Fichtel I, Gotzen L, Vecsei V, Schlegel J (2002) Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthr Cartil 10(1):62-70.
42. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4):393-403.
43. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315-317.
44. Robertson EJ (1997) Derivation and maintenance of embryonic stem cell cultures. Methods Mol Biol 75:173-184. doi:10.1385/0-89603-441-0:173.
45. Woll NL, Heaney JD, Bronson SK (2006) Osteogenic nodule formation from single embryonic stem cell-derived progenitors. Stem Cells Dev 15(6):865-879.
46. Nakagawa T, Lee SY, Reddi AH (2009) Induction of chondrogenesis from human embryonic stem cells without embryoid body formation by bone morphogenetic protein 7 and transforming growth factor beta. 1. Arthritis Rheum 60(12):3686-3692.
47. Daar AS, Bhatt A, Court E, Singer PA (2004) Stem cell research and transplantation: science leading ethics. Transplant Proc 36(8):2504-2506.
48. Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27(5):1050-1056. doi:10.1002/stem.37.
49. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676.
50. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS (2002) Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20(5):1060-1069.
51. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44(8):1928-1942.
52. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211-228.
53. Bosch P, Musgrave DS, Lee JY, Cummins J, Shuler T, Ghivizzani TC, Evans T, Robbins TD (2000) Huard: osteoprogenitor cells within skeletal muscle. J Orthop Res 18(6):933-944.
54. Nakahara H, Goldberg VM, Caplan AI (1991) Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9(4):465-476.
55. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, Thomas K, Austin T, Edwards C, Cuzzourt J, Duenzl M, Lucas PA, Black AC Jr (2001) Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264(1):51-62.
56. He Q, Wan C, Li G (2007) Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25(1):69-77.
57. Huang GT, Gronthos S, Shi S (2009) Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 88(9):792-806.
58. Baghaban Eslaminejad M, Jahangir S, Aghdami N (2011) Mesenchymal stem cells from murine amniotic fluid as a model for preclinical investigation. Arch Iran Med 14(2):96-103.
59. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A (2007) Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25(2):319-331.
60. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4(5):267-274.
61. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11):2739-2749.
62. Javazon EH, Beggs KJ, Flake AW (2004) Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32(5):414-425.
63. DelaRosa O, Lombardo E, Beraza A, Mancheno-Corvo P, Ramirez C, Menta R, Rico L, Camarillo E, Garcia L, Abad JL, Trigueros C, Delgado M, Buscher D (2009) Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 15(10):2795-2806.
64. Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149(2):353-363.
65. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A (2006) Human mesenchymal stem cells modulate Bcell functions. Blood 107(1):367-372.
66. Asari S, Itakura S, Ferreri K, Liu CP, Kuroda Y, Kandeel F, Mullen Y (2009) Mesenchymal stem cells suppress β-cell terminal differentiation. Exp Hematol 37(5):604-615.
67. Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lombardi G, Dazzi F (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83(1):71-76.
68. Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W, Zhao RC (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocytederived dendritic cells. Stem Cells Dev 13(3):263-271.
69. Fox JM, Chamberlain G, Ashton BA, Middleton J (2007) Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137(6):491-502.
70. Granero-Molto F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, Longobardi L, Jansen ED, Mortlock DP, Spagnoli A (2009) Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27(8):1887-1898.
71. Granero-Molto F, Weis JA, Longobardi L, Spagnoli A (2008) Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 8(3):255-268.
72. Lapidot T, Dar A, Kollet O (2005) How do stem cells find their way home? Blood 106(6):1901-1910.
73. Habraken WJ, Wolke JG, Jansen JA (2007) Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59(4-5):234-248.
74. Gladstone HB, McDermott MW, Cooke DD (1995) Implants for cranioplasty. Otolaryngol Clin North Am 28(2):381-400.
75. Lee SH, Shin H (2007) Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 59(4-5):339-359.
76. Middleton JC, Tipton AJ (2000) Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21(23):2335-2346.
77. Eslaminejad MB, Mirzadeh H, Mohamadi Y, Nickmahzar A (2007) Bone differentiation of marrow-derived mesenchymal stem cells using beta-tricalcium phosphate-alginate-gelatin hybrid scaffolds. J Tissue Eng Regen Med 1(6):417-424.
78. Zandi M, Mirzadeh H, Mayer C, Urch H, Eslaminejad MB, Bagheri F, Mivehchi H (2010) Biocompatibility evaluation of nano-rod hydroxyapatite/gelatin coated with nano-HAp as a novel scaffold using mesenchymal stem cells. J Biomed Mater Res A 92(4):1244-1255.
79. Wang M (2006) Composite scaffolds for bone tissue engineering. Am J Biochem Biotechnol 2(2):80-84.
80. Chajra H, Rousseau CF, Cortial D, Ronziere MC, Herbage D, Mallein-Gerin F, Freyria AM (2008) Collagen-based biomaterials and cartilage engineering. Application to osteochondral defects. Biomed Mater Eng 18(1 Suppl):S33-S45.
81. Wakitani S, Goto T, Young RG, Mansour JM, Goldberg VM, Caplan AI (1998) Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. Tissue Eng 4(4):429-444.
82. Knudson W, Casey B, Nishida Y, Eger W, Kuettner KE, Knudson CB (2000) Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum 43(5):1165-1174.
83. Carranza-Bencano A, Armas-Padron JR, Gili-Miner M, Lozano MA (2000) Carbon fiber implants in osteochondral defects of the rabbit patella. Biomaterials 21(21):2171-2176.
84. Defrere J, Franckart A (1992) Teflon/polyurethane arthroplasty of the knee: the first 2 years preliminary clinical experience in a new concept of artificial resurfacing of full thickness cartilage lesions of the knee. Acta Chir Belg 92(5):217-227.
85. Ferretti M, Marra KG, Kobayashi K, Defail AJ, Chu CR (2006) Controlled in vivo degradation of genipin crosslinked polyethylene glycol hydrogels within osteochondral defects. Tissue Eng 12(9):2657-2663.
86. Wang X, Grogan SP, Rieser F, Winkelmann V, Maquet V, Berge ML, Mainil-Varlet P (2004) Tissue engineering of biphasic cartilage constructs using various biodegradable scaffolds: an in vitro study. Biomaterials 25(17):3681-3688.
87. Sharma B, Williams CG, Khan M, Manson P, Elisseeff JH (2007) In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg 119(1):112-120.
88. Yoon BS, Lyons KM (2004) Multiple functions of BMPs in chondrogenesis. J Cell Biochem 93(1):93-103.
89. Matsuda N, Lin WL, Kumar NM, Cho MI, Genco RJ (1992) Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol 63(6):515-525.
90. Chen FM, Zhao YM, Wu H, Deng ZH, Wang QT, Zhou W, Liu Q, Dong GY, Li K, Wu ZF, Jin Y (2006) Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release 114(2):209-222.
91. Kato T, Kawaguchi H, Hanada K, Aoyama I, Hiyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K (1998) Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 16(6):654-659.
92. Grimaud E, Heymann D, Redini F (2002) Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev 13(3):241-257.
93. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ (2005) Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 320(2):269-276.
94. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF (2005) FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203(2):398-409.
95. Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noel D (2009) Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther 4(4):318-329.
96. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S (1998) The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80(7):985-996.
97. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344(5):385-386.
98. Morishita T, Honoki K, Ohgushi H, Kotobuki N, Matsushima A, Takakura Y (2006) Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30(2):115-118.
99. Gronthos S (2004) Reconstruction of human mandible by tissue engineering. Lancet 364(9436):735-736.
100. Paley D, Herzenberg JE, Paremain G, Bhave A (1997) Femoral lengthening over an intramedullary nail. A matched-case comparison with Ilizarov femoral lengthening. J Bone Joint Surg Am 79(10):1464-1480.
101. Kitoh H, Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H, Katoh M, Ishiguro N (2004) Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis--a preliminary result of three cases. Bone 35(4):892-898.
102. Sia IG, Berbari EF (2006) Infection and musculoskeletal conditions: osteomyelitis. Best Pract Res Clin Rheumatol 20(6):1065-1081.
103. Hou T, Xu J, Li Q, Feng J, Zen L (2008) In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. Tissue Eng Part A 14(7):1173-1182.
104. Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405:14-23.
105. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bonemarrow cells. A pilot study. J Bone Joint Surg Am 86-A(6):1153-1160.
106. Wang BL, Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS, Xu SQ, Lou JN, Li ZR (2010) Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 130(7):859-865.
107. Ji WF, Ding WH, Ma ZC, Li J, Tong PJ (2008) Three-tunnels core decompression with implantation of bone marrow stromal cells (bMSCs) and decalcified bone matrix (DBM) for the treatment of early femoral head necrosis. Zhongguo Gu Shang 21(10):776-778.
108. Marsh D (1998) Concepts of fracture union, delayed union, and nonunion. Clin Orthop Relat Res (355 Suppl):S22-S30.
109. Galois L, Bensoussan D, Diligent J, Pinzano A, Henrionnet C, Choufani E, Stoltz JF, Mainard D (2009) Autologous bone marrow graft and treatment of delayed and non-unions of long bones: technical aspects. Biomed Mater Eng 19(4-5):277-281.
110. Siwach RC, Sangwan SS, Singh R, Goel A (2001) Role of percutaneous bone marrow grafting in delayed unions, non-unions and poor regenerates. Indian J Med Sci 55(6):326-336.
111. Hernigou P, Poignard A, Beaujean F, Rouard H (2005) Percutaneous autologous bonemarrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87(7):1430-1437.
112. Scaramuzzo L, Raffaelli L, Spinelli MS, Damis G, Maccauro G, Manicone PF (2011) Orthopaedic and dental abnormalities in osteogenesis imperfecta: a review of the literature. J Biol Regul Homeost Agents 25(3):313-321.
113. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5(3):309-313.
114. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99(13):8932-8937.
115. Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, Leikin S, Vera JC, Mertz EL, Perilli E, Baruffaldi F, Villa I, Farina A, Casasco M, Cetta G, Rossi A, Frattini A, Marini JC, Vezzoni P, Forlino A (2009) In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114(2):459-468.
116. Fraser D (1957) Hypophosphatasia. Am J Med 22(5):730-746.
117. Tadokoro M, Kanai R, Taketani T, Uchio Y, Yamaguchi S, Ohgushi H (2009) New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. J Pediatr 154(6):924-930.
118. Katsube Y, Kotobuki N, Tadokoro M, Kanai R, Taketani T, Yamaguchi S, Ohgushi H (2010) Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient. Gene Ther 17(4):494-502.
119. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M (2007) Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr Cartil 15(2):226-231.
120. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S (2004) Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13(5):595-600.
121. Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H (2007) Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 1(1):74-79.
122. Buckwalter JA, Mankin HJ (1998) Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47:487-504.
123. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 10(3):199-206.
124. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D (2008) Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 11(3):343-353.
125. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B (2011) Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 14(2):211-215.
126. Taylor PC, Feldmann M (2009) Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 5(10):578-582.
127. Nishimoto N (2010) Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin Pharmacol Ther 87(4):483-487.
128. Ringe J, Sittinger M (2009) Tissue engineering in the rheumatic diseases. Arthritis Res Ther 11(1):211.
129. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collageninduced arthritis. Arthritis Rheum 56(4):1175-1186